Insulin-like growth factor-I ameliorates delayed kidney graft function and the acute nephrotoxic effects of cyclosporine

Transplantation

Volumn 64, Issue 2, 1997, Pages 185-190

  Maestri, Marcello ^a   Dafoe, Donald C ^b   Adams, Greeg A ^b   Gaspari, Annalisa ^a   Luzzana, Francesco ^a   Innocente, Francesco ^a   Rademacher, Johannes ^a   Dionigi, Paolo ^a   Barbieri, Annalisa ^a   Zonta, Franco ^a   Zonta, Aris ^a   Rabkin, Ralph ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b STANFORD UNIVERSITY   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RECOMBINANT SOMATOMEDIN C;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; CRYOPRESERVATION; GRAFT REJECTION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ANIMALS; CYCLOSPORINE; DRUG SYNERGISM; GRAFT REJECTION; INSULIN-LIKE GROWTH FACTOR I; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RATS, INBRED WF; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030860990     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00001     Document Type: Article

References (23)

1. Cecka JM Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years: early events affecting transplant success. Transplantation 1992; 53: 59.
2. Finn WF. Prevention of ischemic injury in renal transplantation. Kidney Int 1990; 37: 171.
3. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
4. Rabkin R. Insulin-like growth factor-I treatment of acute renal failure. J Lab Clin Med 1995; 125: 684.
5. Rabkin R, Brody M, Lu LH, Chan C, Shaheen AM, Gillett N. Expression of the genes encoding the rat renal insulin-like growth factor-I system. J Am Soc Nephrol 1995; 6: 1511.
6. Tsao T, Wang J, Fervenza FC, et al. Renal growth hormone-insulin-like growth factor-I system in acute renal failure. Kidney Int 1995; 47: 1658.
7. Hammerman MR. The growth hormone-insulin-like growth factor axis in kidney. Am J Physiol 1989; 26: F503.
8. 2-induced acute renal failure: the effects on renal IGF-I, IGF-I receptor, and IGF-binding protein-I mRNA 1,2. J Am Soc Nephrol 1995; 5: 1782.
9. Miller SB, Martin DR, Kissane J, Hammerman MR. IGF-I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992; 89: 11876.
10. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993; 91: 2281.
11. Bennett WM, Burdmann E, Andoh T, Elzinga L, Franceschini N. Nephrotoxicity of immunosuppressive drugs. Miner Electrolyte Metab 1994; 20: 214.
12. Beschorner WE, Divic J, Pulido H, Yao X, Kenworthy P, Bruce G. Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I. Transplantation 1991; 52: 879.
13. Clark R, Strasser J, McCabe S, Robbins K, Jardieu P. Insulin-like growth factor-I stimulation of lymphopoiesis. J Clin Invest 1993; 92: 540.
14. Jardieu P, Clark R, Mortensen D, Dorshkind K. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol 1994; 152: 4320.
15. Hunt P, Eardley DD. Suppressive effects of insulin and insulin-like growth factor-I on immune responses. J Immunol 1986; 136: 3994.
16. Rajal A, Dawidson IJA, Sentementes JT, Harris RB. Deleterious effect of cyclosporine on the ischemic kidney in the rat and protection by the calcium antagonist verapamil. Transplant Proc 1994; 26: 2894.
17. Gianello P, Ramboux A, Poelart D, et al. Prevention of acute cyclosporine nephrotoxicity by atrial natriuretic factor after ischemia in the rat. Transplantation 1989; 47: 512.
18. Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 1992; 42: 770.
19. Neumayer H-H, Kunzendorf U, Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int 1992; 41 (suppl 36): S87.
20. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92: 1859.
21. Haylor J, Singh I, El Nahas AM. Nitric oxide synthesis prevents vasodilation by insulin-like growth factor I. Kidney Int 1991; 39: 333.
22. Amore A, Gianoglio B, Ghigo D, et al. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995; 6: 1507.
23. Cole E, Skorecki K, Cheung F, Wong PY, Fung LS, Levy GA. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture. Transplant Proc 1988; 20: 732.